Sponsors
Show: August 5, 2012:
- Are new diet drugs worthy of FDA approval?
- What types of cereals are targeted towards children?
- What is the purpose behind plans to launch rapid HIV testing centers?
- What is the impact of teens’ first sexual partners later in life?
- How does work-related stress extend into your home life?
- Is drug testing extensive enough at the Olympics?
- Should high school athletes be mandated to undergo heart screenings?
- View all topics for the week
Sound Medicine is brought to you by:
Are new diet drugs worthy of FDA approval?
views 665
Air date: August 5, 2012
Host: Barbara Lewis
Interview: Joan Temmerman, M.D., assistant professor of clinical medicine at Indiana University School of Medicine.
For the first time in 13 years, the Food and Drug Administration has approved two new diet drugs, Qysymia and Belviq. Previous diet drugs have been pulled from the market after reports of heart complications stemmed from their use. Joan Temmerman, M.D., assistant professor of clinical medicine at Indiana University School of Medicine, shares the history of diet drug complications and her predictions for the level of success of Qysymia and Belviq.
